Tada,

For the longest time now i have had this theory that BP  as a group were dragging their feet on any deal with RVX because of the synergistic effective that apabetalone has on many many ailments and were take away sales from existing drugs in BP pipeline. Not  a good  investment to buy a potential drug that could lose sales unless rvx was purchased to be shelved .......